Hepatocellular carcinoma tumor thrombus entering the right atrium treated with combining percutaneous and intravenous high-dose-rate brachytherapy: a case report

Overview of attention for article published in CVIR Endovascular, October 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (56th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 tweeters

facebook: 1 Facebook page

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 3 Mendeley

Summary Twitter Facebook Dimensions citations

So far, Altmetric has seen 4 tweets from 3 users, with an upper bound of 8,135 followers.

This #CaseReport🔎 involves the combination of intravascular and percutaneous high-dose-rate brachytherapy #HDRBT to treat advanced hepatocellular carcinoma #HCC Read more below to see if this resulted in tumour shrinkage: https://t.co/x7C1efgRIM #Flashba

20 May 2022

Reply Retweet Favourite

RT @cvirendo: Our newest #casereport details the combined use of percutaneous and intravascular #HDRBT to treat #HCC with a #tumorthrombus…

15 Oct 2021

Reply Retweet Favourite

RT @cvirendo: Our newest #casereport details the combined use of percutaneous and intravascular #HDRBT to treat #HCC with a #tumorthrombus…

14 Oct 2021

Reply Retweet Favourite

Our newest #casereport details the combined use of percutaneous and intravascular #HDRBT to treat #HCC with a #tumorthrombus to the #IVC and #RA, demonstrating the feasibility, safety and efficacy of this #palliativetreatment approach Read for free here:

14 Oct 2021

Reply Retweet Favourite